Eli Lilly completes $8bn acquisition of Loxo Oncology to expand oncology portfolio

By on    Pharma Industry News  

Eli Lilly completes $8bn acquisition of Loxo Oncology to expand oncology portfolio

Eli Lilly and Company, the US-based pharmaceutical giant, has finalised its $8 billion acquisition of Connecticut-based biopharmaceutical firm Loxo Oncology, a move expected to significantly enhance its oncology portfolio. The deal, initially announced in January 2019, marks a pivotal step in Lilly’s strategy to focus on precision medicines tailored for cancers driven by specific gene […]

Lilly to acquire Loxo Oncology in $8bn deal: A game-changer in precision cancer treatment

By on    Pharma Industry News  

Lilly to acquire Loxo Oncology in $8bn deal: A game-changer in precision cancer treatment

Eli Lilly and Company (Lilly), a global leader in pharmaceuticals, has made headlines with its announcement to acquire Loxo Oncology, a pioneering biopharmaceutical company based in Stamford, Connecticut. The all-cash deal, valued at $8 billion, is poised to significantly enhance Lilly’s oncology portfolio by integrating Loxo Oncology’s cutting-edge precision medicines. A strategic move in oncology […]